Busulfan test dose
Sponsors
National Cancer Institute (NCI)
Conditions
Autoimmune LymphoproliferativeCommon Variable ImmunodeficiencyGATA2Hematopoietic Stem Cell TransplantationImmune System DiseasesImmunodeficiencyLymphoproliferative DisordersMDS
Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
RecruitingNCT01861106
Start: 2013-07-24End: 2028-12-31Target: 144Updated: 2026-03-24
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
RecruitingNCT04339777
Start: 2020-09-22End: 2027-11-30Target: 66Updated: 2025-09-16
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
RecruitingNCT05027945
Start: 2023-02-23End: 2026-07-01Target: 54Updated: 2026-04-02